The client and his goal:
Bioviiix is a leading global biotech & pharmaceutical company in the field of hemorrhagic coagulopathies and rare diseases, with a focus on the hemophilia segment.
Born from the passion and conviction of a family project, Bioviiix is now the only company in the pharmaceutical industry that is family-owned.
Bioviiix tasked us with developing an app that would offer personalized medical care to hemophilia patients by harnessing the power of artificial intelligence.
Year of release: 2023
The app, called Hemohelp, can provide quick and accurate answers to our users' questions and needs, based on their profile and clinical condition. Hemohelp is the result of a collaboration between Bioviiix and Takeda, a leading manufacturer of clotting factors.
To make this app, we took advantage of the flexibility of flutter for the app and the power of artificial intelligence, thanks to chatgpt's advanced libraries.
In doing so, we have created an AI that can provide quick and accurate answers to our users' questions and needs, based on their profile and clinical condition
In addition to creating the Hemohelp app, the client also asked us to take care of the entire visual identity of the brand, which had to be consistent and recognizable.
Therefore, we designed the logo, which represents the concept of help and protection for patients with hemophilia, and created the offline graphic materials, such as brochures, flyers, posters and gadgets.
We also took care of digital graphic materials, such as banners, icons, images and videos, to promote the service online and on social media.